8-K/A: ProPhase Labs Implements 1-for-10 Reverse Stock Split

ProPhase Labs, Inc. will effect a 1-for-10 reverse stock split of its common stock to meet Nasdaq listing requirements and support its reverse merger strategy.

Summary

• ProPhase Labs, Inc. is implementing a 1-for-10 reverse stock split of its common stock, effective December 22, 2025, at 8:00 a.m. Eastern Time.
• The reverse stock split was approved by stockholders on November 30, 2025, and by the Board of Directors on November 30, 2025.
• The primary purpose is to increase the per-share trading price of the common stock to meet Nasdaq Capital Markets' continued listing requirements.
• The action is also connected to the company's reverse merger strategy, as previously disclosed in a Definitive Proxy Statement on Schedule 14A filed October 21, 2025.
• Following the split, every 10 shares of common stock will automatically combine into one share.
• Fractional shares will be rounded up to the nearest whole share, meaning any stockholder otherwise entitled to a fractional share will receive one whole share.
• The reverse stock split will uniformly affect all stockholders and will not alter percentage ownership, except for adjustments due to fractional shares.
• The par value of the common stock ($0.0005 per share) and the number of authorized shares will not change.
• Proportionate adjustments will be made to outstanding equity awards, warrants, and other convertible securities.
• The company expects its common stock to begin trading on a split-adjusted basis on Nasdaq under the existing symbol PRPH on an expected first trading date in 2025, with a new CUSIP number.
• Approximately 5,768,951 shares of common stock will be issued and outstanding after the reverse stock split.

Sentiment

Score: 4

Explanation: The reverse stock split is a necessary technical action to maintain Nasdaq listing, which is a positive outcome for a negative situation (low stock price). It does not reflect fundamental business improvement but prevents a significant negative event (delisting). The connection to a reverse merger strategy adds a layer of strategic intent.

Positives

• The reverse stock split addresses Nasdaq's continued listing requirements, preventing potential delisting and maintaining market access.
• Rounding up fractional shares benefits stockholders who would otherwise receive less than a whole share.

Negatives

• The necessity of a reverse stock split often indicates a low stock price, which can be perceived negatively by the market and may signal underlying business challenges.
• While the split increases the per-share price, it does not fundamentally change the company's market capitalization or intrinsic value, and can sometimes lead to further price declines post-split.

Risks

• Failure to maintain the minimum bid price requirement on Nasdaq could lead to delisting, which the reverse stock split aims to mitigate.
• The reverse merger strategy, while mentioned as a reason for the split, inherently carries risks that are not detailed in this filing but were disclosed in a previous proxy statement.

Future Outlook

The company expects its common stock to begin trading on a split-adjusted basis on Nasdaq under a new CUSIP number on an expected first trading date in 2025. This action is intended to support the company's reverse merger strategy and ensure continued compliance with Nasdaq listing requirements.

Management Comments

• No direct quotes from management are provided in this filing, but the report was signed by Ted Karkus, Chairman of the Board and Chief Executive Officer.

Industry Context

Reverse stock splits are a common corporate action undertaken by companies whose stock price has fallen below exchange minimums, typically to avoid delisting. This move by ProPhase Labs aligns with standard practices for maintaining exchange compliance, particularly for companies pursuing strategic initiatives like reverse mergers where a higher share price might be beneficial.

Comparison to Industry Standards

• The 1-for-10 reverse stock split ratio is within the typical range for such actions, which often vary from 1-for-2 to 1-for-20 or more, depending on the extent of the price increase required.
• The primary motivation, meeting Nasdaq's continued listing requirements, is a standard reason for reverse splits across various industries, similar to actions taken by other companies facing minimum bid price deficiencies.
• The rounding up of fractional shares is a shareholder-friendly approach, though not universally adopted, as some companies opt to pay cash in lieu of fractional shares.

Corporate Governance

Stakeholder Impact

• Shareholders will hold fewer shares but maintain the same percentage ownership in the company, with fractional shares rounded up to a whole share.
• Holders of outstanding equity awards, warrants, and other convertible securities will see proportionate adjustments to the number of underlying shares and exercise/conversion prices.
• The action aims to maintain the company's listing on Nasdaq, which benefits all stakeholders by ensuring continued market access and liquidity.

Next Steps

• The reverse stock split will become effective on December 22, 2025, at 8:00 a.m. Eastern Time.
• Common Stock is expected to begin trading on a Reverse Stock Split-adjusted basis on Nasdaq at the market open on an expected first trading date in 2025.
• The company's Common Stock is expected to begin trading under a new CUSIP number.
• The company's transfer agent will issue new stock certificates to registered stockholders, and book-entry/brokerage accounts will be automatically adjusted.

Key Dates

Recommendation

The reverse stock split is a technical maneuver to address Nasdaq listing requirements and facilitate a reverse merger strategy. It does not inherently change the company's fundamental value or business operations. While it removes the immediate threat of delisting, investors should hold and await further details on the reverse merger and subsequent financial performance before making a more definitive investment decision. The underlying reasons for the low stock price prior to the split warrant continued scrutiny.

Keywords

ProPhase Labs, PRPH, Reverse Stock Split, Nasdaq Listing, Corporate Governance, Stock Split, Reverse Merger, SEC Filing, 8-K/A